- Home
- LEE vs NRSN Comparison
LEE vs NRSN Comparison
Compare LEE & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEE
- NRSN
- Stock Information
- Founded
- LEE 1890
- NRSN 2017
- Country
- LEE United States
- NRSN Israel
- Employees
- LEE N/A
- NRSN N/A
- Industry
- LEE Newspapers/Magazines
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- LEE Consumer Discretionary
- NRSN Health Care
- Exchange
- LEE Nasdaq
- NRSN Nasdaq
- Market Cap
- LEE 33.8M
- NRSN 31.1M
- IPO Year
- LEE N/A
- NRSN 2021
- Fundamental
- Price
- LEE N/A
- NRSN $1.22
- Analyst Decision
- LEE
- NRSN Buy
- Analyst Count
- LEE 0
- NRSN 2
- Target Price
- LEE N/A
- NRSN $14.00
- AVG Volume (30 Days)
- LEE 54.9K
- NRSN 404.8K
- Earning Date
- LEE 08-07-2025
- NRSN 09-17-2025
- Dividend Yield
- LEE N/A
- NRSN N/A
- EPS Growth
- LEE N/A
- NRSN N/A
- EPS
- LEE N/A
- NRSN N/A
- Revenue
- LEE $581,809,000.00
- NRSN N/A
- Revenue This Year
- LEE N/A
- NRSN N/A
- Revenue Next Year
- LEE N/A
- NRSN N/A
- P/E Ratio
- LEE N/A
- NRSN N/A
- Revenue Growth
- LEE N/A
- NRSN N/A
- 52 Week Low
- LEE $3.79
- NRSN $0.80
- 52 Week High
- LEE $19.63
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- LEE N/A
- NRSN 44.56
- Support Level
- LEE N/A
- NRSN $1.12
- Resistance Level
- LEE N/A
- NRSN $1.26
- Average True Range (ATR)
- LEE 0.00
- NRSN 0.06
- MACD
- LEE 0.00
- NRSN 0.01
- Stochastic Oscillator
- LEE 0.00
- NRSN 36.87
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.